DrugPatentWatch Database Preview

Nifurtimox - Generic Drug Details

« Back to Dashboard

What are the generic sources for nifurtimox and what is the scope of patent protection?

Nifurtimox is the generic ingredient in one branded drug marketed by Bayer Healthcare and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for nifurtimox

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	23
Clinical Trials:	20
Patent Applications:	12
What excipients (inactive ingredients) are in nifurtimox?	nifurtimox excipients list
DailyMed Link:	nifurtimox at DailyMed

Recent Clinical Trials for nifurtimox

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Juan D. Maya	Phase 2
Drugs for Neglected Diseases initiative	Phase 3
Laboratorio Elea Phoenix S.A.	Phase 3

See all nifurtimox clinical trials

US Patents and Regulatory Information for nifurtimox

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Healthcare	LAMPIT	nifurtimox	TABLET;ORAL	213464-001	Aug 6, 2020		RX	Yes	No
Bayer Healthcare	LAMPIT	nifurtimox	TABLET;ORAL	213464-002	Aug 6, 2020		RX	Yes	Yes
Bayer Healthcare	LAMPIT	nifurtimox	TABLET;ORAL	213464-001	Aug 6, 2020		RX	Yes	No
Bayer Healthcare	LAMPIT	nifurtimox	TABLET;ORAL	213464-002	Aug 6, 2020		RX	Yes	Yes